Prokaryotics Inc

Prokaryotics Inc., based in Union, NJ, is an innovative antibacterial discovery organization focused on addressing the global crisis of antibiotic resistance through the development of novel therapeutics targeting multidrug-resistant bacteria. The company emerged from the licensing of several antibiotic programs from Merck & Co., Inc., led by a team of former senior scientists dedicated to optimizing early-stage programs.

With a commitment to creativity, collaboration, and a deep understanding of bacterial physiology, Prokaryotics aims to develop new antibiotics that effectively target bacterial cell envelope assembly processes. Their approach seeks to leverage innovative screening strategies and medicinal chemistry expertise to create new classes of antibiotics that can treat otherwise resistant bacterial infections.

Generated from the website